A Review On Study Of Peripartum Cardiomyopathy Prevention Strategies

  • Unique Paper ID: 183202
  • PageNo: 882-888
  • Abstract:
  • Factors associated With Right Ventricular Dysfunction and Elevated Pulmonary Artery Systolic Pressure were identified as the main factors leading to death. In few cases Left Ventricular Dysfunction also has caused morbidity and mortality. Heart failure during pregnancy was recognized as early as 1849, but it was first described as a distinctive form of cardiomyopathy only in the 1930s. In 1971, Demakis etal described 27 patients who presented during the puerperium with cardiomegaly, abnormal electrocardiographic findings, and congestive heart failure, and named the syndrome peripartum cardiomyopathy. The European Society of Cardiology recently defined peripartum cardiomyopathy as a form of dilated cardiomyopathy that presents with signs of heart failure in the last month of pregnancy or within 5 months of delivery. Peripartum cardiomyopathy is relatively rare but can be life-threatening. The National Hospital Discharge Survey (1990–2002) estimated that it occurs in 1 in every 2,289 live births in the United States. The disease appears to be more common in African American women. The rate varies in other populations: it is highest in Haiti, with 1 case in 300 live births, which is nearly 10 times higher than in the United States. The reason for such a variation remains unclear. Although early reports suggested the death rate was nearly 50%, more recent reports show it to be 0 to 5% in the United States, and the higher numbers in the earlier reports likely represented publication bias

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{183202,
        author = {Hari Srija Bhanu and Sk. Shakeela and Madhumanchi Prathyusha},
        title = {A Review On Study Of Peripartum Cardiomyopathy Prevention Strategies},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {3},
        pages = {882-888},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=183202},
        abstract = {Factors associated With Right Ventricular Dysfunction and Elevated Pulmonary Artery Systolic Pressure were identified as the main factors leading to death. In few cases Left Ventricular Dysfunction also has caused morbidity and mortality. Heart failure during pregnancy was recognized as early as 1849, but it was first described as a distinctive form of cardiomyopathy only in the 1930s. In 1971, Demakis etal described 27 patients who presented during the puerperium with cardiomegaly, abnormal electrocardiographic findings, and congestive heart failure, and named the syndrome peripartum cardiomyopathy. The European Society of Cardiology recently defined peripartum cardiomyopathy as a form of dilated cardiomyopathy that presents with signs of heart failure in the last month of pregnancy or within 5 months of delivery.  Peripartum cardiomyopathy is relatively rare but can be life-threatening. The National Hospital Discharge Survey (1990–2002) estimated that it occurs in 1 in every 2,289 live births in the United States. The disease appears to be more common in African American women. The rate varies in other populations: it is highest in Haiti, with 1 case in 300 live births, which is nearly 10 times higher than in the United States. The reason for such a variation remains unclear. Although early reports suggested the death rate was nearly 50%, more recent reports show it to be 0 to 5% in the United States, and the higher numbers in the earlier reports likely represented publication bias},
        keywords = {ventricular dysfunction, heart failure, peripartum, cardiomyopathy},
        month = {August},
        }

Cite This Article

Bhanu, H. S., & Shakeela, S., & Prathyusha, M. (2025). A Review On Study Of Peripartum Cardiomyopathy Prevention Strategies. International Journal of Innovative Research in Technology (IJIRT), 12(3), 882–888.

Related Articles